pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Parkinson's Disease · news · pharmadog
← back to Parkinson's Disease
News mentioning Parkinson's Disease
13
stories
8d
AbbVie's next-gen dopamine therapy for Parkinson's gets FDA approval
endpoints
17d
With pioneering ADHD data, Alkermes eyes orexin agonist as potential ‘company changer’
fiercebiotech
17d
A Parkinson's biotech debut, fundraising campaign and licensing deal
endpoints
18d
SK pens $315M pact with fellow South Korean company for Parkinson’s prospect
fiercebiotech
27d
Reeling from past failures, Parkinson's pipeline enters 'era of diversification'
biospace
Sep 4, 26
10 life sciences startups selected for accelerator program
biospace
Sep 1, 26
9 midsize drugmakers climb aboard Trump’s MFN train
biospace
Aug 14, 26
MapLight dims preclinical programs to make phase 3-ready schizophrenia drug shine brighter
fiercebiotech
Aug 6, 26
BioVie’s stock sinks 50% as company uses composite endpoint to make case for Parkinson’s program
fiercebiotech
Aug 5, 26
Lilly drops another gene therapy trial from $1B Prevail buyout
fiercebiotech
Aug 3, 26
Supernus and Indivior merge to create CNS mega-company with 11 approved drugs
biospace
Jul 21, 26
Jupiter enters psychedelics space with $100M deal for PharmAla's MDMA drug
fiercebiotech
May 11, 26
New home for Novo's Parkinson's cell therapy; GSK's deal to sell drug in China
endpoints
